AlarMax Promotes Matt Ehrman to Senior Vice President, Supply Chain

AlarMax is pleased to announce the promotion of Matt Ehrman to Senior Vice President, Supply Chain, reflecting the company's commitment to building a world-class supply chain infrastructure to support its dealers, branches, and vendor partners nationwide. https://mma.prnewswire.com/media/2804166/AlarMax_Matt_Headshot.jpg Ehrman brings decades of experience across security, distribution, and retail channels, with a reputation for forging high-impact supplier […]

Connectbase Wins “Best Data Service Innovation” at the 2025 Global Connectivity Awards

Connectbase, the Operating System for Connected Commerce, today announced it has been named winner of the “Best Data Service Innovation” at the Global Connectivity Awards 2025, hosted by Capacity Media. This honor recognizes Connectbasegroundbreaking work in transforming how the global connectivity ecosystem transacts – turning fragmented data into intelligent, location-driven insights that power digital commerce

Express Wash Concepts Expands Greater Cincinnati Presence with Acquisition of Montgomery Road Zips Car Wash Location

Express Wash Concepts(EWC), one of the nation's fastest-growing express car wash operators, today announced the continued expansion of its Flying Ace Express Car Washbrand through the acquisition of a new site located at 12167 Montgomery Road in Cincinnati, Ohio. This strategic addition strengthens EWC's growing presence across Greater Cincinnati and increases the company's express wash

MLTX CLASS ACTION: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Stock Plummets 90% — Investors Urged to Contact BFA Law

(NASDAQ:MLTX), NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain

Lilly to Acquire Adverum Biotechnologies

Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases Eli Lilly and Company (NYSE: LLY) and Adverum Biotechnologies,

CLPS Incorporation Unveils Web3-Ready Issuance Platform, Making a Strategic Leap into the Stablecoin Economy

CLPS Incorporation (the “Company” or “CLPS”) (Nasdaq: CLPS), today announced, through its wholly-owned Hong Kong subsidiary, Qinson Credit Card Services Limited (“QCC”), the integration of major stablecoin payment and settlement functions into its core credit card system, CAKU. A stablecoin is a type of digital financial instrument that uses crypto-native programmable contracts to maintain price

MLTX CLASS ACTION: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Stock Plummets 90% — Investors Urged to Contact BFA Law

MLTX CLASS ACTION: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Stock Plummets 90% — Investors Urged to Contact BFA Law GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX)

Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation Scientific Retreat

ATNM-400 targets a novel,non-PSMA antigen implicated in disease biology withcontinued expression following androgen receptor pathway inhibitor (ARPI) therapy and 177Lu-PSMA-617 therapy, enabling potent activity independent of PSMA expression ATNM-400 demonstrated superior efficacy overPSMA-targeted radioligand therapy(177Lu-PSMA-617 and 225Ac-PSMA-617) with enhanced tumor control and prolonged survival in low-PSMA and treatment-resistant models Demonstrated durable anti-tumor responses, exceeding those

Vonage Unveils First-of-its-Kind AI and Network Innovation at Dreamforce 2025

Thousands of businesses experienced Vonage APIs integrated with Vonage Contact Center for Salesforce Agentforce 360 Platform Vonage, a part of Ericsson (NASDAQ: ERIC), showcased the future of customer engagement at Dreamforce 2025. Vonage and Salesforce, longstanding strategic partners, unveiled a breakthrough innovation – Vonage Contact Center integrated with Vonage Network APIs for Agentforce 360 users,

Maximum Fair Price Strategies for IPAY2027 Readiness, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how the maximum fair price (MFP) process is evolving and what it means for manufacturers, payers and policymakers navigating the Medicare landscape. Attendees will learn how the Trump administration could aggressively seek MFPs relative to the savings that the Centers for Medicare & Medicaid Services (CMS) achieved in IPAY 2026

Scroll to Top